Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vivos Therapeutics (VVOS) Non-cash Items (2019 - 2025)

Vivos Therapeutics has reported Non-cash Items over the past 6 years, most recently at $177000.0 for Q4 2025.

  • Quarterly Non-cash Items changed N/A to $177000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $177000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $177000.0 for FY2025, N/A changed from the prior year.
  • Non-cash Items was $177000.0 for Q4 2025 at Vivos Therapeutics, up from $174000.0 in the prior quarter.
  • Over five years, Non-cash Items peaked at $65.5 million in Q4 2022 and troughed at $89000.0 in Q4 2023.
  • The 4-year median for Non-cash Items is $1.8 million (2023), against an average of $6.3 million.
  • Year-over-year, Non-cash Items soared 3351.0% in 2022 and then crashed 99.86% in 2023.
  • A 4-year view of Non-cash Items shows it stood at $1.9 million in 2021, then soared by 3351.0% to $65.5 million in 2022, then crashed by 99.86% to $89000.0 in 2023, then soared by 98.88% to $177000.0 in 2025.
  • Per Business Quant, the three most recent readings for VVOS's Non-cash Items are $177000.0 (Q4 2025), $174000.0 (Q2 2025), and $151000.0 (Q1 2025).